Indication

Cryptococcosis

Cryptococcosis is an invasive fungal infection primarily caused by encapsulated yeasts of the *Cryptococcus* genus, most commonly *Cryptococcus neoformans* and *Cryptococcus gattii*. Read more about Cryptococcosis

9 drugs 9 manufacturers

Advertisement

Drugs that treat it

Common Cryptococcosis therapies.

Showing 1–9 of 9 drugs

Filter & compare in the drug finder →Opens the drug finder with Cryptococcosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cryptococcosis.

Cryptococcosis is an invasive fungal infection primarily caused by encapsulated yeasts of the *Cryptococcus* genus, most commonly *Cryptococcus neoformans* and *Cryptococcus gattii*.

The disease is typically acquired through the inhalation of environmental basidiospores or desiccated yeast cells, which initially establish a pulmonary infection that can remain localized or disseminate hematogenously.

While it predominantly presents as a severe opportunistic infection causing subacute meningoencephalitis and pneumonia in immunocompromised hosts—especially individuals with advanced HIV disease, solid organ transplants, or prolonged immunosuppressive therapy—it can also affect immunocompetent hosts.

Hallmark pathophysiologic and clinical features include a marked neurotropism, a thick antiphagocytic polysaccharide capsule, elevated intracranial pressure, and systemic dissemination involving the central nervous system, lungs, skin, and other organs.

Personalize your experience

Follow Cryptococcosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it